FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1081 April 9, 1998 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Frank E. Johnson and Katherine S. Virgo, with five others. 554 pp. St. Louis, Mosby, 1997. $69. ISBN 0-8151-4925-5.

Clinical follow-up is a neglected field in oncology. Although attention is focused on detecting and treating primary cancers and cancer recurrence, follow-up strategies all too frequently do not receive the same attention. Many of these strategies are based on one's best guess and consensus rather than on objective evidence. This is lamentable, given that in the United States an estimated 1 million to 2 million new cases of cancer will be seen in 1998. Fortunately, the majority will be treated with curative intent and then followed. However, the type of follow-up is inconsistent. For example, factors such as the centers . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.